| Product NDC: | 65862-074 |
| Proprietary Name: | Citalopram Hydrobromide |
| Non Proprietary Name: | Citalopram Hydrobromide |
| Active Ingredient(s): | 10 mg/5mL & nbsp; Citalopram Hydrobromide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65862-074 |
| Labeler Name: | Aurobindo Pharma Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077812 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060828 |
| Package NDC: | 65862-074-24 |
| Package Description: | 240 mL in 1 BOTTLE (65862-074-24) |
| NDC Code | 65862-074-24 |
| Proprietary Name | Citalopram Hydrobromide |
| Package Description | 240 mL in 1 BOTTLE (65862-074-24) |
| Product NDC | 65862-074 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Citalopram Hydrobromide |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20060828 |
| Marketing Category Name | ANDA |
| Labeler Name | Aurobindo Pharma Limited |
| Substance Name | CITALOPRAM HYDROBROMIDE |
| Strength Number | 10 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |